Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 24326568)

1.

Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss.

Ahluwalia GS.

J Investig Dermatol Symp Proc. 2013 Dec;16(1):S73-6. doi: 10.1038/jidsymp.2013.30.

2.

Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.

Fagien S, Walt JG, Carruthers J, Cox SE, Wirta D, Weng E, Beddingfield FC 3rd.

Aesthet Surg J. 2013 Aug 1;33(6):789-98. doi: 10.1177/1090820X13495887. Epub 2013 Jul 19.

PMID:
23873891
3.

Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.

Harii K, Arase S, Tsuboi R, Weng E, Daniels S, VanDenburgh A.

Aesthetic Plast Surg. 2014 Apr;38(2):451-60. doi: 10.1007/s00266-014-0293-7. Epub 2014 Mar 19. Erratum in: Aesthetic Plast Surg. 2014 Oct;38(5):1071-2.

4.

Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.

Smith S, Fagien S, Whitcup SM, Ledon F, Somogyi C, Weng E, Beddingfield FC 3rd.

J Am Acad Dermatol. 2012 May;66(5):801-6. doi: 10.1016/j.jaad.2011.06.005. Epub 2011 Sep 6.

PMID:
21899919
5.

A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis.

Yoelin SG, Fagien S, Cox SE, Davis PG, Campo A, Caulkins CA, Gallagher CJ.

Dermatol Surg. 2014 Oct;40(10):1118-24. doi: 10.1097/01.DSS.0000452658.83001.d9.

PMID:
25229783
6.

Bimatoprost 0.03% solution (latisse) for eyelash enhancement.

[No authors listed]

Med Lett Drugs Ther. 2009 Jun 1;51(1313):43-4. No abstract available.

PMID:
19478690
7.

Treatment of eyebrow hypotrichosis using bimatoprost: a randomized, double-blind, vehicle-controlled pilot study.

Beer KR, Julius H, Dunn M, Wilson F.

Dermatol Surg. 2013 Jul;39(7):1079-87. doi: 10.1111/dsu.12199. Epub 2013 Apr 25.

PMID:
23617229
8.

Management of hypotrichosis of the eyelashes: Focus on bimatoprost.

Fagien S.

Clin Cosmet Investig Dermatol. 2010 Apr 13;3:39-48.

9.

Bimatoprost in the treatment of eyelash hypotrichosis.

Law SK.

Clin Ophthalmol. 2010 Apr 26;4:349-58.

10.

Long-term safety and efficacy of bimatoprost solution 0ยท03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.

Glaser DA, Hossain P, Perkins W, Griffiths T, Ahluwalia G, Weng E, Beddingfield FC.

Br J Dermatol. 2015 May;172(5):1384-94. doi: 10.1111/bjd.13443. Epub 2015 Mar 7.

PMID:
25296533
11.
12.

Management of hypotrichosis of the eyelashes: focus on bimatoprost.

Fagien S.

Plast Surg Nurs. 2015 Apr-Jun;35(2):82-91. doi: 10.1097/PSN.0000000000000097.

PMID:
26020474
13.

Topical bimatoprost for the treatment of eyebrow hypotrichosis.

Schweiger ES, Pinchover L, Bernstein RM.

J Drugs Dermatol. 2012 Jan;11(1):106-8.

PMID:
22206085
14.

The role of bimatoprost eyelash gel in chemotherapy-induced madarosis: an analysis of efficacy and safety.

Morris CL, Stinnett S, Woodward J.

Int J Trichology. 2011 Jul;3(2):84-91. doi: 10.4103/0974-7753.90809.

15.

Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy.

Sira M, Verity DH, Malhotra R.

Aesthet Surg J. 2012 Sep;32(7):822-4. doi: 10.1177/1090820X12455659.

PMID:
22942109
16.

Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.

Yoelin S, Walt JG, Earl M.

Dermatol Surg. 2010 May;36(5):638-49. doi: 10.1111/j.1524-4725.2010.01519.x. Epub 2010 Apr 1.

PMID:
20384751
17.

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects.

Wirta D, Baumann L, Bruce S, Ahluwalia G, Weng E, Daniels S.

J Clin Aesthet Dermatol. 2015 Apr;8(4):11-20.

18.

Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.

Cohen JL.

Dermatol Surg. 2010 Sep;36(9):1361-71. doi: 10.1111/j.1524-4725.2010.01522.x. Review.

PMID:
20384750
19.

Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.

Centofanti M, Oddone F, Chimenti S, Tanga L, Citarella L, Manni G.

Am J Ophthalmol. 2006 Dec;142(6):1059-60. Epub 2006 Aug 7.

PMID:
17157592
20.

Successful use of bimatoprost in the treatment of alopecia of the eyelashes.

Zaheri S, Hughes B.

Clin Exp Dermatol. 2010 Jun;35(4):e161-2. doi: 10.1111/j.1365-2230.2009.03755.x. Epub 2009 Nov 19. No abstract available.

PMID:
19925481
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk